학술논문

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
Document Type
Article
Source
In Annals of Oncology September 2008 19(9):1541-1546
Subject
Language
ISSN
0923-7534